CompuGoup Med SE/ DE000A288904 /
| 2024-07-09 4:53:37 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 18.0400USD | - | 400 Turnover: 5,774 |
-Bid Size: - | -Ask Size: - | 786.77 mill.USD | - | - |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 82.8000 | 83.7000 | 88.1000 | 91.8000 | 100.1000 | ||||||
| Intangible Assets | 534.6000 | 536.5000 | 668.3000 | 1,088.1000 | 1,214.3000 | ||||||
| Long-Term Investments | 12.4000 | 12 | 11.4000 | 12.9000 | 24.5000 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 12.5000 | 19.6000 | 27.5000 | 18.2000 | 20.6000 | ||||||
| Accounts Receivable | 116.1000 | 111.4000 | 103 | 137.2000 | 147.2000 | ||||||
| Cash and Cash Equivalents | 30.4000 | 25.3000 | 46.4000 | 75.9000 | 107.3000 | ||||||
| Current Assets | 178 | 191.8000 | 232.9000 | 308.1000 | 370.8000 | ||||||
| Total Assets | 825 | 848.3000 | 1,065.9000 | 1,565.8000 | 1,790.8000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 43.9000 | 39.3000 | 47.1000 | 64.5000 | 93.2000 | ||||||
| Long-term debt | 327.1000 | 319.7000 | 424.5000 | 470.2000 | 587.1000 | ||||||
| Liabilities to Banks | 370.4000 | 337.1000 | 471.2000 | 515.3000 | 694.7000 | ||||||
| Provisions | 97.5000 | 100 | 130.8000 | 149.5000 | 170.8000 | ||||||
| Liabilities | 589 | 575.3000 | 805.9000 | 926.8000 | 1,192.1000 | ||||||
| Share Capital | 53.2190 | 53.2190 | 53.2190 | 53.7350 | 53.7350 | ||||||
| Total Equity | 236.1000 | 273 | 259.9000 | 638.9000 | 612.3000 | ||||||
| Minority Interests | 1.9000 | 2.1000 | .8000 | .3000 | .2000 | ||||||
| Total liabilities equity | 825 | 848.3000 | 1,065.9000 | 1,565.8000 | 1,790.8000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 582.4000 | 717 | 745.8000 | 837.3000 | 1,025.3000 | ||||||
| Depreciation (total) | 38.3000 | 44.6000 | 62.9000 | 75.5000 | 110.7000 | ||||||
| Operating Result | 90.1000 | 137.9000 | 115.3000 | 121.8000 | 102.7000 | ||||||
| Interest Income | -23.3000 | -8.8000 | -5.7000 | -10.4000 | -4.8000 | ||||||
| Income Before Taxes | 65.6000 | 128.8000 | 107.7000 | 110.4000 | 97.9000 | ||||||
| Income Taxes | 33.8000 | 36.2000 | 41.6000 | 37 | 28.8000 | ||||||
| Minority Interests Profit | -.4000 | -.3000 | -.3000 | -.2000 | -.0600 | ||||||
| Net Income | 31.3000 | 92.3000 | 65.8000 | 73.2000 | 69 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 85.8000 | 136.3000 | 110.5000 | 149.9000 | 165.3000 | ||||||
| Cash Flow from Investing Activities | -54.9000 | -47.5000 | -139.4000 | -457.1000 | -164 | ||||||
| Cash Flow from Financing | -28 | -93.4000 | 49.7000 | 338.1000 | 30.2000 | ||||||
| Decrease / Increase in Cash | 2.9000 | -4.5000 | 20.7000 | 30.9000 | 31.5000 | ||||||
| Employees | 4,572 | 4,955 | 5,627 | 7,814 | 8,598 | ||||||
